| Closed |
SWOG-9400 |
Treatment of Adult Lymphoblastic Leukemia: A Phase II Trial of An Induction Regimen Including PEG-L-Asparaginase in Previously Untreated Patients, Followed By Allogeneic Bone Marrow Transplantation… |
7/15/1995 |
5/1/2000 |
62% |
|
Published
|
| Closed |
SWOG-9350 |
Phase II Disseminated Malignant Melanoma |
8/1/1994 |
11/13/1996 |
39% |
|
Published
|
| Closed |
SWOG-9349 |
A Randomized Phase II Trial of CHOP with G-CSF Support or ProMACE-CytaBOM with G-CSF Support for Treatment of Non-Hodgkin's Lymphoma |
9/15/1994 |
1/15/1997 |
100% |
|
Published
|
| Closed |
SWOG-9348 |
Evaluation of the Standard BCNU/DTIC/Cisplatin/Tamoxifen Regimen in Disseminated Malignant Melanoma, Phase II |
4/15/1994 |
4/15/1995 |
85% |
|
Published
|
| Closed |
SWOG-9346 |
Advanced Prostate |
5/15/1995 |
9/1/2008 |
88% |
|
Published
|
| Closed |
SWOG-9343 |
Advanced Prostate |
8/15/1994 |
1/15/1997 |
100% |
|
Published
|
| Closed |
SWOG-9342 |
Cardiac Evaluation with MUGA scan at year 5-8 and year 10-11 OR at years 10-14 only |
2/15/1997 |
11/15/2003 |
43% |
|
Published
|
| Closed |
SWOG-9341 |
High-Dose Ifosfamide (HDI) with Mesna and Granulocyte-Colony Stimulating Factor (rhG-CSF) in Unresectable Malignant Mesothelioma |
9/15/1994 |
9/15/1996 |
100% |
|
Published
|
| Closed |
SWOG-9339 |
Evaluation of Topotecan in Esophageal Carcinoma, Phase II |
3/1/1994 |
12/15/1995 |
100% |
|
Published
|
| Closed |
SWOG-9338 |
Advanced Renal |
12/15/1994 |
9/1/1997 |
100% |
|
Published
|
| Closed |
SWOG-9333 |
Mito/VP-16 vs DNR/Ara-C for Elderly AML |
1/15/1995 |
12/1/1998 |
84% |
|
Published
|
| Closed |
SWOG-9328 (ECOG-S9328) |
Autologous Stem Cell Transplantation for Patients with Acute Myeloid Leukemia Beyond First Remission: A Randomized Trial of Post-Transplant Therapy with Interleukin-2 Versus Observation Phase III |
7/1/1994 |
6/1/1996 |
4% |
|
|
| Closed |
SWOG-9327 |
Randomized Phase II Pilot Study of Pentoxifylline (Trental®) and Placebo in Patients with Metastatic Malignancy and Anorexia/Cachexia Syndrome |
2/15/1996 |
12/15/1997 |
15% |
|
|
| Closed |
SWOG-9326 |
Phase II Trial of Altretamine for Consolidation of Clinical Complete Response in Patients with Stage III Epithelial Ovarian Cancer |
9/1/1993 |
7/1/1997 |
100% |
|
Published
|
| Closed |
SWOG-9324 |
Phase II Trial of Vinorelbine Tartrate (Navelbine®) for Patients with Relapsed Ovarian Cancer |
3/15/1995 |
7/1/1997 |
100% |
|
Published
|
| Closed |
SWOG-9321 |
Previously Untreated MM |
1/15/1994 |
9/15/2000 |
90% |
|
Published
|
| Closed |
SWOG-9320 |
AIDS-RELATED: ProMACE-CytaBOM w/trimethoprim sulfa, G-CSF, and antiretroviral therapy (followed by brain RT) |
5/1/1994 |
12/1/2000 |
100% |
|
Published
|
| Closed |
SWOG-9318 |
Recombinant Human Erythropoietin (r-HuEPO) as an Adjunct to Radiation Therapy and Cisplatin for Patients with Stages II-B, III and IV-A Carcinoma of the Cervix, Phase II |
12/15/1994 |
3/1/1999 |
98% |
|
Published
|
| Closed |
SWOG-9316 |
Testicular |
11/1/1995 |
10/15/1996 |
2% |
|
|
| Closed |
SWOG-9314 |
ER and PgR Predicting Response to Tamoxifen |
9/1/1993 |
12/15/1995 |
91% |
|
Published
|
